PlainRecalls
FDA Drug Low Class III Terminated

Enalapril Maleate tablets, USP, 5mg, 1000-count bottles, Rx only, Manufactured by: Wockhardt Limited H-14/2, M.I.D.C. Area, Waluj, Aurangabad, Maharashtra, India, Distributed by: Wockhardt, USA LLC, 20 Waterview Blvd, Parsippany, NJ 07054, USA. NDC: 64679-924-03;

Reported: November 1, 2017 Initiated: August 22, 2017 #D-0051-2018

Product Description

Enalapril Maleate tablets, USP, 5mg, 1000-count bottles, Rx only, Manufactured by: Wockhardt Limited H-14/2, M.I.D.C. Area, Waluj, Aurangabad, Maharashtra, India, Distributed by: Wockhardt, USA LLC, 20 Waterview Blvd, Parsippany, NJ 07054, USA. NDC: 64679-924-03;

Reason for Recall

Failed Impurities/Degradation Specifications: 5mg strength being recalled for out of specification results for related compound.

Details

Recalling Firm
Wockhardt Usa Inc.
Units Affected
5050 bottles
Distribution
Nationwide in the USA
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Enalapril Maleate tablets, USP, 5mg, 1000-count bottles, Rx only, Manufactured by: Wockhardt Limited H-14/2, M.I.D.C. Area, Waluj, Aurangabad, Maharashtra, India, Distributed by: Wockhardt, USA LLC, 20 Waterview Blvd, Parsippany, NJ 07054, USA. NDC: 64679-924-03;. Recalled by Wockhardt Usa Inc.. Units affected: 5050 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications: 5mg strength being recalled for out of specification results for related compound.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 1, 2017. Severity: Low. Recall number: D-0051-2018.